Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Biology

Background:

• Vitamin D analogs improve survival in chronic kidney disease patients with cardiovascular issues.
• Smooth muscle cell activation is implicated in cardiovascular diseases.
• The precise mechanisms by which vitamin D analogs affect gene expression in smooth muscle cells remain unclear.

Purpose of the Study:

• To investigate the effects of vitamin D analogs, specifically calcitriol and paricalcitol, on gene expression in human coronary artery smooth muscle cells.
• To identify novel genes regulated by the vitamin D receptor (VDR) in smooth muscle cells.
• To understand the role of VDR in regulating smooth muscle cell proliferation and related processes.

Main Methods:

• Human coronary artery smooth muscle cells were treated with calcitriol or paricalcitol.
• DNA microarray technology was employed to analyze global gene expression profiles.
• Real-time RT-PCR was used to validate the regulation of specific target genes.

Main Results:

• Both calcitriol and paricalcitol demonstrated similar effects on gene expression.
• Paricalcitol treatment resulted in 115 up-regulated and 61 down-regulated genes.
• Paricalcitol dose- and time-dependently regulated genes involved in cell proliferation (IGF1, WT1, TGFbeta3) and down-regulated natriuretic peptide precursor B and thrombospondin 1.
• Both analogs inhibited smooth muscle cell proliferation in a dose-dependent manner.

Conclusions:

• This study identified novel VDR-regulated genes in smooth muscle cells.
• The findings provide insights into VDR's role in regulating smooth muscle cell growth, thrombogenicity, fibrinolysis, and endothelial regeneration.
• Vitamin D analogs modulate key pathways relevant to cardiovascular complications in chronic kidney disease.